Clinical Trial: A Phase 1 Study of FXR0906 in Healthy Adults With or Without Elevated Triglycerides

U.S., Aug. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07766759) titled 'A Phase 1 Study of FXR0906 in Healthy Adults With or Without Elevated Triglycerides' on July 27.

Brief Summary: This is a phase 1, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics effects of a single dose of FXR0906 injection or placebo in Chinese healthy adult volunteers with or without TG increase.

Study Start Date: Aug. 25

Study Type: INTERVENTIONAL

Condition: Healthy Adult Volunteers

Intervention: DRUG: Intervention1: FXR0906 injection

A single dose of FXR0906 (dose 1 ) will be administered on Day 1 by subcutaneous injection

DRUG: Intervention2...